Filing Details
- Accession Number:
- 0001640334-22-002377
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-10 06:11:07
- Reporting Period:
- 2022-11-09
- Accepted Time:
- 2022-11-10 06:11:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
895464 | Yubo International Biotech Ltd | YBGJ | Electromedical & Electrotherapeutic Apparatus (3845) | 113074326 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1828515 | Lina Liu | Room 105, Building 5, Xishiku Avenue Xicheng District Beijing F4 00000 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2022-11-09 | 4,728,000 | $0.50 | 9,101,400 | No | 4 | S | Indirect | By Focus Draw Group Limited |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Focus Draw Group Limited |
Footnotes
- The shares of Class A Common Stock are held directly by Focus Draw Group Limited. Ms. Lina Liu is the sole Director of Focus Draw Group Limited, and as such, Ms. Lina Liu may be deemed to have voting and investment power over such shares held by Focus Draw Group Limited. Ms. Lina Liu disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), except to the extent of her indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.